FINANCIAL COUNSELORS INC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 307 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
FINANCIAL COUNSELORS INC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2024$325,079
-7.8%
25,122
-1.0%
0.01%
-16.7%
Q1 2024$352,459
-3.3%
25,375
-0.6%
0.01%
-14.3%
Q4 2023$364,356
-8.2%
25,533
-0.5%
0.01%
-12.5%
Q3 2023$396,945
+98153.7%
25,659
-0.2%
0.01%0.0%
Q2 2023$404
-4.7%
25,699
-0.2%
0.01%
-11.1%
Q1 2023$424
+4.7%
25,756
-0.7%
0.01%0.0%
Q4 2022$405
-99.9%
25,947
-0.3%
0.01%
+12.5%
Q3 2022$338,000
-7.9%
26,032
-0.4%
0.01%
-11.1%
Q2 2022$367,000
-8.0%
26,149
-6.1%
0.01%
+12.5%
Q1 2022$399,000
+3.1%
27,836
-1.9%
0.01%0.0%
Q4 2021$387,000
-17.8%
28,378
-1.4%
0.01%
-20.0%
Q3 2021$471,000
-3.1%
28,784
-0.2%
0.01%
-9.1%
Q2 2021$486,000
-9.3%
28,850
-1.7%
0.01%
-8.3%
Q1 2021$536,0000.0%29,342
-0.3%
0.01%
-7.7%
Q4 2020$536,000
+1.7%
29,430
-0.4%
0.01%
-13.3%
Q3 2020$527,000
-1.3%
29,535
-0.9%
0.02%
-11.8%
Q2 2020$534,000
+17.9%
29,800
-0.2%
0.02%
-15.0%
Q1 2020$453,000
-23.9%
29,863
-0.9%
0.02%
-4.8%
Q4 2019$595,000
+14.0%
30,139
-0.6%
0.02%0.0%
Q3 2019$522,000
-3.0%
30,325
-0.2%
0.02%
-4.5%
Q2 2019$538,000
-14.1%
30,380
-1.1%
0.02%
-18.5%
Q1 2019$626,00030,7110.03%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Y.D. More Investments Ltd 1,498,811$24,700,3805.57%
TFG Asset Management GP Ltd 1,903,662$31,372,3504.20%
Clean Yield Group 542,342$8,937,7963.81%
MANAGED ASSET PORTFOLIOS, LLC 1,467,952$24,1923.67%
Mondrian Investment Partners LTD 4,081,715$67,266,6631.48%
Sippican Capital Advisors 82,235$1,355,2331.30%
Psagot Value Holdings Ltd. / (Israel) 174,300$2,8301.18%
Clal Insurance Enterprises Holdings Ltd 4,365,500$71,9431.08%
Legacy Wealth Asset Management, LLC 123,303$2,032,0330.73%
BRANDES INVESTMENT PARTNERS, LP 1,817,972$29,960,1750.64%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders